The Correlation of Biological Activity and Chemical Structure of Quinolizidinyl Derivatives as Inhibitor of Alzheimer's Disease with Linear and Non-linear Models

被引:0
|
作者
Ghasemi, G. [1 ]
Rashtehroodi, A. Nemati [2 ]
机构
[1] Islamic Azad Univ, Rasht Branch, Dept Chem, Rasht, Iran
[2] Payame Noor Univ, Dept Chem, Sari Branch, Sari, Iran
来源
ANALYTICAL AND BIOANALYTICAL CHEMISTRY RESEARCH | 2016年 / 3卷 / 02期
关键词
QSAR model; Genetic Algorithm; Artificial Neural Network; Alzheimer's disease; Quinolizidinyl derivatives;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this research, QSAR study has been carried out on quinolizidinyl derivatives as potent inhibitors of Acetyl and butyrylcholin esterase in Alzheimer's disease. Despite significant research efforts in industry and academia, there are currently no diseases modifying therapies available to treat this illness. Significant evidence suggests that the pathology of AD is linked to generation of beta-amyloid peptides (A beta) through proteolytic processing of amyloid precursor protein (APP). Genetic algorithm (GA), Jack-Knife and stepwise multiple linear regressions (stepwise-MLR) were used to create non-linear and linear QSAR models. The root-mean square errors of the training set and the validation set for GA-ANN model using Jack-Knife method, were 0.1406, 0.2165 and R-2 was 0.90. Also, the R and R-2 values in the gas phase were obtained as 0.88 and 0.78 from GA-stepwise MLR model, respectively. Also, we suggest that compounds No. 4, 6, 10, 14, 24, 26 and 34 have the most appropriate structure for the design of drugs to pharmacists. Electronegativities, atomic polarizability and atomic van der Waals volumes were important descriptors in our study. Geometry optimization of compounds was carried out using the B3LYP method employing a 6-31G (d) basis set.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 43 条
  • [31] Novel pyridine-containing sultones: Structure-activity relationship and biological evaluation as selective AChE inhibitors for the treatment of Alzheimer's disease
    Zhang, Hong
    Wu, Chengyao
    Chen, Xing
    Zhang, Ziwen
    Jiang, Xia
    Qin, Hua-Li
    Tang, Wenjian
    CHEMMEDCHEM, 2021, 16 (20) : 3189 - 3200
  • [32] Characterization of the dynamic behavior of neural activity in Alzheimer's disease: exploring the non-stationarity and recurrence structure of EEG resting-state activity
    Nunez, Pablo
    Poza, Jesus
    Gomez, Carlos
    Barroso-Garcia, Veronica
    Maturana-Candelas, Aaron
    Tola-Arribas, Miguel A.
    Cano, Monica
    Hornero, Roberto
    JOURNAL OF NEURAL ENGINEERING, 2020, 17 (01)
  • [33] A novel approach to perform linear discriminant analyses for a 4-way alzheimer's disease diagnosis based on an integration of pearson's correlation coefficients and empirical cumulative distribution function
    Mabrouk, Besma
    Hamida, Ahmed Ben
    Mabrouki, Noura
    Bouzidi, Nouha
    Mhiri, Chokri
    MULTIMEDIA TOOLS AND APPLICATIONS, 2024, 83 (31) : 76687 - 76703
  • [34] Predicting biological activity and design of 5-HT6 antagonists through assessment of ANN-QSAR models in the context of Alzheimer's disease
    de Sousa, Daniel S.
    da Silva, Aldineia P.
    Chiari, Laise P. A.
    de Angelo, Rafaela M.
    de Sousa, Alexsandro G.
    Honorio, Kathia M.
    da Silva, Alberico B. F.
    JOURNAL OF MOLECULAR MODELING, 2024, 30 (10)
  • [35] Log-linear models for assessing gene–age interaction and their application to case-control studies of the apolipoprotein E (apoE) gene in Alzheimer's disease
    Noriko Tanaka
    Toru Kinoshita
    Takashi Asada
    Yasuo Ohashi
    Journal of Human Genetics, 2003, 48 : 520 - 524
  • [36] New cholinesterase inhibitors for Alzheimer's disease: Structure activity for relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives
    Larik, Fayaz Ali
    Shah, Muhammad Shakil
    Saeed, Aamer
    Shah, Hamid Saeed
    Channar, Pervaiz Ali
    Bolte, Michael
    Iqbal, Jamshed
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 116 : 144 - 150
  • [37] Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
    Wang, Guoqiao
    Aschenbrenner, Andrew J.
    Li, Yan
    McDade, Eric
    Liu, Lei
    Benzinger, Tammie L. S.
    Bateman, Randall J.
    Morris, John C.
    Hassenstab, Jason J.
    Xiong, Chengjie
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 450 - 457
  • [38] Log-linear models for assessing gene-age interaction and their application to case-control studies of the apolipoprotein E (apoE) gene in Alzheimer's disease
    Tanaka, N
    Kinoshita, T
    Asada, T
    Ohashi, Y
    JOURNAL OF HUMAN GENETICS, 2003, 48 (10) : 520 - 524
  • [39] Lie symmetry, chaos optimal control in non-linear fractional-order diabetes mellitus, human immunodeficiency virus, migraine Parkinson's diseases models: using evolutionary algorithms
    Mohammadi, Shaban
    Hejazi, S. Reza
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2024, 27 (05) : 651 - 679
  • [40] Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation
    Makhaeva, Galina F.
    Kovaleva, Nadezhda, V
    Boltneva, Natalia P.
    Lushchekina, Sofya, V
    Rudakova, Elena, V
    Stupina, Tatyana S.
    Terentiev, Alexey A.
    Serkov, Igor, V
    Proshin, Alexey N.
    Radchenko, Eugene, V
    Palyulin, Vladimir V.
    Bachurin, Sergey O.
    Richardson, Rudy J.
    BIOORGANIC CHEMISTRY, 2020, 94